CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: Dasatinib Induces G1 Arrest, Decreases Phosphorylation, and Mediates Relocalization of FOXO1, 3a, and 4 to the Nucleus in Primary CD34+ CML Cells